1. Plym A, Clements M, Voss M, Holmberg L, Stattin P, Lambe M. Duration of sick leave after active surveillance, surgery or radiotherapy for localised prostate cancer: a nationwide cohort study. BMJ Open. 2020 Mar 9.
  2. Beckmann K, Garmo H, Nilsson P, Franck Lissbrant I, Widmark A, Stattin P. Radical radiotherapy for prostate cancer: patterns of care in Sweden 1998-2016. Acta Oncol. 2020 Mar 3. Sammanfattning. 
  3. Mehtälä J, Zong J, Vassilev Z, Brobert G, Gabarró MS, Stattin P, Khanfir H. Overall survival and second primary malignancies in men with metastatic prostate cancer. PloS One, 2020 Feb 21. Sammanfattning. 
  4. Thomsen F, Westerberg M, Garmo H, Robinson D, Holmberg L, Ulmert D, Stattin P. Prediction of metastatic prostate cancer by prostate-specific antigen in combination with T stage and Gleason Grade. Nationwide, population-based register study. PloS One, 2020 Jan.  Sammanfattning.
  5. Jansson F, Folkvaljon F, Stattin P, Bratt O, Akre O. Risk of Postoperative Upstaging or Upgrading Among Men with Low-Risk Familial Prostate Cancer. J Urol. 2020 Jan. Sammanfattning. 
  6. Bratt O, Drevin L, Prütz KG, Carlsson S, Wennberg L, Stattin P. Prostate cancer in kidney transplant recipients – a nationwide register study. BJU Int. 2020 Jan 19. Sammanfattning